Mechanisms of tumor resistance to small-molecule vascular disrupting agents: treatment and rationale of combination therapy
about
Tumor resistance to vascular disrupting agents: mechanisms, imaging, and solutionsRandomized Phase II Evaluation of Bevacizumab Versus Bevacizumab Plus Fosbretabulin in Recurrent Ovarian, Tubal, or Peritoneal Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study.TRPM8: a potential target for cancer treatment.Antiangiogenesis and vascular disrupting agents in cancer: circumventing resistance and augmenting their therapeutic utility.Cross-drug resistance to sunitinib induced by doxorubicin in endothelial cells.The vascular disrupting agent combretastatin A-4 phosphate causes prolonged elevation of proteins involved in heme flux and function in resistant tumor cells.Realizing the Potential of Vascular Targeted Therapy: The Rationale for Combining Vascular Disrupting Agents and Anti-Angiogenic Agents to Treat Cancer.Starvation tactics using natural compounds for advanced cancers: pharmacodynamics, clinical efficacy, and predictive biomarkers.Intra-individual comparison of therapeutic responses to vascular disrupting agent CA4P between rodent primary and secondary liver cancers.
P2860
Q26774355-19F3420F-E1D1-45BE-BB78-474917CC5743Q37130150-07BE2BE9-B321-4EDB-A803-2F23A69309A4Q38709214-BFA08C83-4F23-4908-8B24-868D9E53465BQ38757723-16545138-2B2D-4DA2-85C9-4EC805CBAC2EQ41921173-198067C3-ED6A-4E09-B4B4-51D5EC2D1716Q49302678-6E67C628-40B2-4181-A8F0-9AD1C6BFB622Q51795514-3EDDA6DF-D49C-4AB2-A222-AA2A92C93451Q55365628-3EA2BFFB-6C37-4930-9863-E0BB91CE21D6Q55506772-E7A36A5F-F4AC-41BD-912C-8DDB146F867A
P2860
Mechanisms of tumor resistance to small-molecule vascular disrupting agents: treatment and rationale of combination therapy
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Mechanisms of tumor resistance ...... tionale of combination therapy
@ast
Mechanisms of tumor resistance ...... tionale of combination therapy
@en
Mechanisms of tumor resistance ...... tionale of combination therapy
@nl
type
label
Mechanisms of tumor resistance ...... tionale of combination therapy
@ast
Mechanisms of tumor resistance ...... tionale of combination therapy
@en
Mechanisms of tumor resistance ...... tionale of combination therapy
@nl
prefLabel
Mechanisms of tumor resistance ...... tionale of combination therapy
@ast
Mechanisms of tumor resistance ...... tionale of combination therapy
@en
Mechanisms of tumor resistance ...... tionale of combination therapy
@nl
P2093
P1476
Mechanisms of tumor resistance ...... tionale of combination therapy
@en
P2093
Chi-Hua Guo
Kiran Gurung
Xue-Yuan Wu
P304
P356
10.1016/J.JFMA.2012.09.017
P407
P577
2013-03-01T00:00:00Z